Fulgent Genetics Stock Performance
| FLGT Stock | USD 23.44 0.27 1.14% |
The firm shows a Beta (market volatility) of 0.0334, which means not very significant fluctuations relative to the market. As returns on the market increase, Fulgent Genetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fulgent Genetics is expected to be smaller as well. At this point, Fulgent Genetics has a negative expected return of -0.34%. Please make sure to confirm Fulgent Genetics' downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Fulgent Genetics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Fulgent Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (2.09) | Five Day Return (11.97) | Year To Date Return (10.32) | Ten Year Return 150 | All Time Return 150 |
1 | Piper Sandler Issues Positive Forecast for Fulgent Genetics Stock Price | 11/11/2025 |
2 | Disposition of 671 shares by Paul Kim of Fulgent Genetics at 30.0 subject to Rule 16b-3 | 11/21/2025 |
3 | Fulgent Genetics Reaches New 1-Year High - Heres Why - MarketBeat | 11/25/2025 |
4 | Disposition of 2944 shares by Ming Hsieh of Fulgent Genetics at 30.15 subject to Rule 16b-3 | 11/26/2025 |
5 | Disposition of 943 shares by Gao Hanlin of Fulgent Genetics at 29.5695 subject to Rule 16b-3 | 11/28/2025 |
6 | Disposition of 1131 shares by Paul Kim of Fulgent Genetics at 28.52 subject to Rule 16b-3 | 12/01/2025 |
7 | Disposition of 1075 shares by Gao Hanlin of Fulgent Genetics at 28.3318 subject to Rule 16b-3 | 12/02/2025 |
8 | Jian Xie Sells 1,140 Shares of Fulgent Genetics Stock - MarketBeat | 12/04/2025 |
9 | Fulgent Genetics Cut to Hold at Wall Street Zen | 12/16/2025 |
10 | FLGT to Acquire Bako StrataDx Assets to Expand Pathology Platform | 12/23/2025 |
11 | Disposition of 8031 shares by Jian Xie of Fulgent Genetics at 16.29 subject to Rule 16b-3 | 01/06/2026 |
12 | Fulgent Genetics Stock Price Up 7.3 percent - Time to Buy - MarketBeat | 01/07/2026 |
13 | Buyout Rumor Why Fulgent Genetics Inc stock remains undervalued - Watch List Fast Entry and Exit Trade Plans - moha.gov.vn | 01/13/2026 |
14 | Disposition of 1556 shares by Paul Kim of Fulgent Genetics at 15.45 subject to Rule 16b-3 | 01/22/2026 |
15 | Disposition of 985 shares by Gao Hanlin of Fulgent Genetics at 15.45 subject to Rule 16b-3 | 01/23/2026 |
16 | Disposition of 3004 shares by Paul Kim of Fulgent Genetics at 27.53 subject to Rule 16b-3 | 01/26/2026 |
17 | Disposition of 2951 shares by Jian Xie of Fulgent Genetics at 16.29 subject to Rule 16b-3 | 02/02/2026 |
| Begin Period Cash Flow | 97.5 M | |
| Total Cashflows From Investing Activities | -58.4 M |
Fulgent Genetics Relative Risk vs. Return Landscape
If you would invest 2,908 in Fulgent Genetics on November 12, 2025 and sell it today you would lose (564.00) from holding Fulgent Genetics or give up 19.39% of portfolio value over 90 days. Fulgent Genetics is currently does not generate positive expected returns and assumes 1.9758% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Fulgent, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Fulgent Genetics Target Price Odds to finish over Current Price
The tendency of Fulgent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 23.44 | 90 days | 23.44 | about 98.0 |
Based on a normal probability distribution, the odds of Fulgent Genetics to move above the current price in 90 days from now is about 98.0 (This Fulgent Genetics probability density function shows the probability of Fulgent Stock to fall within a particular range of prices over 90 days) .
Fulgent Genetics Price Density |
| Price |
Predictive Modules for Fulgent Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fulgent Genetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Fulgent Genetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fulgent Genetics is not an exception. The market had few large corrections towards the Fulgent Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fulgent Genetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fulgent Genetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 1.81 | |
Ir | Information ratio | -0.01 |
Fulgent Genetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fulgent Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fulgent Genetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fulgent Genetics generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 283.47 M. Net Loss for the year was (43.82 M) with profit before overhead, payroll, taxes, and interest of 130.14 M. | |
| About 56.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Disposition of 2951 shares by Jian Xie of Fulgent Genetics at 16.29 subject to Rule 16b-3 |
Fulgent Genetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fulgent Stock often depends not only on the future outlook of the current and potential Fulgent Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fulgent Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 258.1 M |
Fulgent Genetics Fundamentals Growth
Fulgent Stock prices reflect investors' perceptions of the future prospects and financial health of Fulgent Genetics, and Fulgent Genetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fulgent Stock performance.
| Return On Equity | -0.0392 | ||||
| Return On Asset | -0.0363 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.18) % | ||||
| Current Valuation | 355.4 M | ||||
| Shares Outstanding | 30.91 M | ||||
| Price To Earning | 3.95 X | ||||
| Price To Book | 0.64 X | ||||
| Price To Sales | 2.30 X | ||||
| Revenue | 283.47 M | ||||
| Gross Profit | 130.14 M | ||||
| EBITDA | (48.99 M) | ||||
| Net Income | (43.82 M) | ||||
| Cash And Equivalents | 515.4 M | ||||
| Cash Per Share | 17.03 X | ||||
| Total Debt | 8.47 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 5.29 X | ||||
| Book Value Per Share | 36.49 X | ||||
| Cash Flow From Operations | 21.06 M | ||||
| Earnings Per Share | (1.40) X | ||||
| Market Capitalization | 724.59 M | ||||
| Total Asset | 1.22 B | ||||
| Retained Earnings | 590.47 M | ||||
| Working Capital | 280.67 M | ||||
| Current Asset | 2.93 M | ||||
| Current Liabilities | 686 K | ||||
About Fulgent Genetics Performance
Assessing Fulgent Genetics' fundamental ratios provides investors with valuable insights into Fulgent Genetics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fulgent Genetics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 19.97 | 24.94 | |
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Capital Employed | (0.06) | (0.06) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.03) | (0.04) |
Things to note about Fulgent Genetics performance evaluation
Checking the ongoing alerts about Fulgent Genetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fulgent Genetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fulgent Genetics generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 283.47 M. Net Loss for the year was (43.82 M) with profit before overhead, payroll, taxes, and interest of 130.14 M. | |
| About 56.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Disposition of 2951 shares by Jian Xie of Fulgent Genetics at 16.29 subject to Rule 16b-3 |
- Analyzing Fulgent Genetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fulgent Genetics' stock is overvalued or undervalued compared to its peers.
- Examining Fulgent Genetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fulgent Genetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fulgent Genetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fulgent Genetics' stock. These opinions can provide insight into Fulgent Genetics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.